BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25210071)

  • 1. Similar frequencies of Pseudomonas aeruginosa isolates producing KPC and VIM carbapenemases in diverse genetic clones at tertiary-care hospitals in Medellín, Colombia.
    Vanegas JM; Cienfuegos AV; Ocampo AM; López L; del Corral H; Roncancio G; Sierra P; Echeverri-Toro L; Ospina S; Maldonado N; Robledo C; Restrepo A; Jiménez JN
    J Clin Microbiol; 2014 Nov; 52(11):3978-86. PubMed ID: 25210071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.
    Vanegas JM; Parra OL; Jiménez JN
    BMC Infect Dis; 2016 Sep; 16(1):463. PubMed ID: 27585707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics.
    Ocampo AM; Chen L; Cienfuegos AV; Roncancio G; Chavda KD; Kreiswirth BN; Jiménez JN
    Antimicrob Agents Chemother; 2016 Jan; 60(1):332-42. PubMed ID: 26503660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization of isolates of carbapenemase-producing Pseudomonas aeruginosa from seven Colombian provinces].
    Saavedra SY; Duarte C; González MN; Realpe ME
    Biomedica; 2014 Apr; 34 Suppl 1():217-23. PubMed ID: 24968053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.
    Crespo MP; Woodford N; Sinclair A; Kaufmann ME; Turton J; Glover J; Velez JD; Castañeda CR; Recalde M; Livermore DM
    J Clin Microbiol; 2004 Nov; 42(11):5094-101. PubMed ID: 15528701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea.
    Yoo JS; Yang JW; Kim HM; Byeon J; Kim HS; Yoo JI; Chung GT; Lee YS
    Int J Antimicrob Agents; 2012 Apr; 39(4):300-4. PubMed ID: 22325122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.
    Mikucionyte G; Zamorano L; Vitkauskiene A; López-Causapé C; Juan C; Mulet X; Oliver A
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):195-200. PubMed ID: 26638216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea.
    Seok Y; Bae IK; Jeong SH; Kim SH; Lee H; Lee K
    J Antimicrob Chemother; 2011 Dec; 66(12):2791-6. PubMed ID: 21933788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular surveillance of carbapenemase-producing
    Schäfer E; Malecki M; Tellez-Castillo CJ; Pfennigwerth N; Marlinghaus L; Higgins PG; Mattner F; Wendel AF
    Antimicrob Resist Infect Control; 2019; 8():208. PubMed ID: 31893042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominance of international high-risk clones in carbapenemase-producing
    Pragasam AK; Veeraraghavan B; Anandan S; Narasiman V; Sistla S; Kapil A; Mathur P; Ray P; Wattal C; Bhattacharya S; Deotale V; Subramani K; Peter JV; Hariharan TD; Ramya I; Iniyan S; Walia K; Ohri VC
    Indian J Med Microbiol; 2018; 36(3):344-351. PubMed ID: 30429385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.
    Patzer JA; Walsh TR; Weeks J; Dzierzanowska D; Toleman MA
    J Antimicrob Chemother; 2009 Feb; 63(2):269-73. PubMed ID: 19095681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominance of international 'high-risk clones' among metallo-β-lactamase-producing Pseudomonas aeruginosa in the UK.
    Wright LL; Turton JF; Livermore DM; Hopkins KL; Woodford N
    J Antimicrob Chemother; 2015 Jan; 70(1):103-10. PubMed ID: 25182064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt.
    Zafer MM; Al-Agamy MH; El-Mahallawy HA; Amin MA; El Din Ashour S
    BMC Infect Dis; 2015 Mar; 15():122. PubMed ID: 25880997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima.
    Kouda S; Ohara M; Onodera M; Fujiue Y; Sasaki M; Kohara T; Kashiyama S; Hayashida S; Harino T; Tsuji T; Itaha H; Gotoh N; Matsubara A; Usui T; Sugai M
    J Antimicrob Chemother; 2009 Jul; 64(1):46-51. PubMed ID: 19398456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
    Liakopoulos A; Mavroidi A; Katsifas EA; Theodosiou A; Karagouni AD; Miriagou V; Petinaki E
    BMC Infect Dis; 2013 Oct; 13():505. PubMed ID: 24168643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla
    PÉrez-VÁzquez M; Sola-Campoy PJ; Zurita ÁM; Ávila A; GÓmez-Bertomeu F; SolÍs S; LÓpez-Urrutia L; GÓnzalez-BarberÁ EM; Cercenado E; Bautista V; Lara N; Aracil B; Oliver A; Campos J; Oteo-Iglesias J;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.
    Slekovec C; Robert J; van der Mee-Marquet N; Berthelot P; Rogues AM; Derouin V; Cholley P; Thouverez M; Hocquet D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):921-926. PubMed ID: 30826996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of VIM-4 metallo-β-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital.
    Merradi M; Kassah-Laouar A; Ayachi A; Heleili N; Menasria T; Hocquet D; Cholley P; Sauget M
    J Infect Dev Ctries; 2019 Apr; 13(4):284-290. PubMed ID: 32045372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.